Search Result "alpha synuclein aggregates"
Is alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?
Journal: Current Alzheimer Research
Volume: 4 Issue: 4 Year: 2007 Page: 446-457
Author(s): M. Windisch, H. J. Wolf, B. Hutter-Paier, A. Hofmeister, R. Wronski
Structural and Aggregation Properties of Alpha-Synuclein Linked to Phospholipase A2 Action
Journal: Protein & Peptide Letters
Volume: 25 Issue: 4 Year: 2018 Page: 368-378
Author(s): Kerensa Broersen,Violeta Ruiperez,Bazbek Davletov
The Therapeutical Potential of Alpha-Synuclein Antiaggregatory Agents for Dementia with Lewy Bodies
Journal: Current Medicinal Chemistry
Volume: 15 Issue: 2 Year: 2008 Page: 2748-2759
Author(s): Katrin Beyer, Aurelio Ariza
Meclofenoxate Inhibits Aggregation of Alpha-synuclein in vitro
Journal: Protein & Peptide Letters
Volume: 30 Issue: 5 Year: 2023 Page: 361-366
Author(s):
Biophysics of Parkinsons Disease: Structure and Aggregation of α- Synuclein
Journal: Current Protein & Peptide Science
Volume: 10 Issue: 5 Year: 2009 Page: 483-499
Author(s): Vladimir N. Uversky, David Eliezer
Does Human Alpha-Synuclein Behave Like Prions?
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 20 Issue: 6 Year: 2021 Page: 480-486
Author(s): Yasir H. Siddique
Is Alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?
Journal: Current Alzheimer Research
Volume: 4 Issue: 5 Year: 2007 Page: 556-561
Author(s): Manfred Windisch, Hans-Jorg Wolf, Birgit Hutter-Paier, Robert Wronski
Membrane Interactions of Oligomeric Alpha-Synuclein: Potential Role in Parkinsons Disease
Journal: Current Protein & Peptide Science
Volume: 11 Issue: 5 Year: 2010 Page: 334-342
Author(s): Bart D. van Rooijen, Mireille M.A.E. Claessens, Vinod Subramaniam
Ignored Avenues in Alpha-Synuclein Associated Proteopathy
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 7 Year: 2014 Page: 1246-1257
Author(s): Rimpy K. Chowhan,Shruti Mittal,Tanveer A. Dar,Mohammad A. Kamal,Laishram R. Singh
ParkinParkinson’s Disease: Alpha Synuclein, Heme Oxygenase and Biotherapeutic Countermeasuresson’s Disease: Alpha Synuclein, Heme Oxygenase and Biotherapeutic Countermeasures
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 2 Year: 2018 Page: 2317-2321
Author(s): David D. Haines,Maxim V. Trushin,Stephen Rose,Iloki Assanga Simon Bernard,Fadia F. Mahmoud